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The American Psychiatric Association and the World Health Organisation provide distinct 
trauma-based psychiatric diagnoses in the Diagnostic and Statistical Manual, fifth edition 
(DSM-5), and the 11th version of the International Classification of Diseases (ICD-11), 
respectively. DSM-5 conceptualises posttraumatic stress disorder (PTSD) as a single, broad 
diagnosis, whereas two ‘sibling-disorders’ of PTSD and Complex PTSD (CPTSD) are 
proposed for ICD-11. The objectives of the current study were to (1) compare prevalence 
rates based on each diagnostic system, (2) identify clinical and behavioural factors that 
distinguish ICD-11 CPTSD and PTSD diagnoses, and (3) examine the comorbidity rates 
associated with ICD-11 CPTSD and DSM-5 PTSD. A predominately female, clinical sample 
(N = 106) completed self-report scales to measure ICD-11 PTSD and CPTSD, DSM-5 PTSD, 
depression, anxiety, borderline personality disorder (BPD), dissociation, reckless behaviour, 
and suicidal ideation and self-injurious behaviour (SI/SIB). Significantly more people met 
diagnostic status as per the DSM-5 guidelines compared to the ICD-11 (90.4% vs 79.8%). An 
ICD-11 CPTSD diagnosis was distinguishable from an ICD-11 PTSD diagnosis by higher 
levels of dissociation, depression, and BPD. Comorbidity rates were higher for ICD-11 
CPTSD compared to DSM-5 PTSD. The clinical and theoretical implications of these 
findings are discussed.  
Key words: Posttraumatic stress disorder (PTSD); Complex PTSD (CPTSD); ICD-11; DSM-
5; dissociation; comorbidity.  
Introduction 
The American Psychiatric Association (APA) and the World Health Organization 
(WHO) provide distinct descriptions of trauma-related psychopathology. In the fifth edition 
of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5: APA, 2013), 
posttraumatic stress disorder (PTSD) is described by 20 symptoms across four symptom 
clusters: intrusions (5 symptoms), avoidance (2 symptoms), negative alterations in cognition 
and mood (NACM: 7 symptoms), and arousal (6 symptoms). A diagnosis of PTSD requires 
the presence of at least one intrusion, one avoidance, two NACM, and two arousal symptoms, 
plus evidence of functional impairment. In contrast, in the upcoming 11th version of the 
International Classification of Diseases (ICD-11), the WHO propose two ‘sibling’ disorders: 
PTSD and Complex PTSD (CPTSD: Maercker et al., 2013). PTSD is substantially refined 
compared to DSM-5 and includes six symptoms across three clusters, each directly related to 
one’s traumatic exposure: re-experiencing in the here and now (2 symptoms), avoidance (2 
symptoms), and sense of threat (2 symptoms). Diagnosis of PTSD requires the presence of 
one symptom per cluster, plus evidence of functional impairment. CPTSD is a broader 
diagnosis that includes the core PTSD symptoms plus an additional set of ‘disturbances in 
self-organisation’ (DSO) symptoms that are intended to capture pervasive psychological 
disturbances associated with traumatic exposure. These symptoms are distributed across three 
clusters: affective dysregulation, negative self-concept, and disturbances in relationships. A 
CPTSD diagnosis requires that the PTSD criteria be met in addition to endorsement of 
symptoms from each of the DSO clusters. 
To date, numerous confirmatory factor analysis and latent class analysis studies have 
provided empirical support for the construct validity of ICD-11 PTSD and CPTSD (see 
Brewin et al., in press). Several studies have also found that CPTSD, compared to PTSD, is 
associated with an increased incidence of childhood trauma (Cloitre et al., 2013; Hyland et al. 
2017a), and higher levels of functional impairment (Karatzias et al., 2017; Murphy et al., 
2016). Relatively less research however has focused on the identification of clinical and 
behavioural correlates that are associated with an elevated risk of CPTSD. Emerging 
evidence suggests that depression, negative trauma-cognitions, reduced distress tolerance 
(Hyland et al., 2017b), dissociation, anxiety, and aggression (Elklit, Hyland, & Shevlin, 
2014) may be associated with an increased risk of CPTSD. At present there are few 
psychological treatments specifically designed to treat CPTSD (Cloitre et al., 2010) therefore 
the identification of psychological factors that meaningfully differentiate CPTSD from PTSD 
may have important implications for the development of targeted treatments for CPTSD. 
Studies that have compared prevalence rates based on the DSM-5 and ICD-11 
guidelines have reported a general trend for significantly more people to meet the diagnostic 
criteria of the DSM-5 (e.g., Hansen et al., 2015; Hyland et al., 2017b; O’Donnell et al., 2014). 
The introduction of the new NACM symptoms in DSM-5 has also prompted suggestions that 
DSM-5 PTSD may have more in common with ICD-11 CPTSD than ICD-11 PTSD 
(Friedman, 2013). Only one study however has directly compared the clinical correlates of 
DSM-5 PTSD and ICD-11 CPTSD in the same study. In a sample of 190 African-American 
women, ICD-11 CPTSD was associated with significantly higher levels of comorbidity with 
depression, alcohol dependence, and substance dependence as compared to DSM-5 PTSD 
(Powers et al., 2017). These differences in comorbidity suggest that despite the similarity in 
symptom content, ICD-11 CPTSD and DSM-5 PTSD may have distinct clinical 
presentations, with ICD-11 CPTSD being associated with higher levels of psychiatric 
distress. 
The current study had three objectives. First, prevalence rates based on the DSM-5 
(PTSD) and ICD-11 (PTSD and CPTSD) criteria were statistically compared. On the basis of 
existing data, it was hypothesised that significantly more people would meet diagnostic 
criteria according to the DSM-5. Second, we assessed whether those with an ICD-11 CPTSD 
diagnosis were significantly different from those with an ICD-11 PTSD diagnosis on a range 
of clinical and behavioural variables including depression, anxiety, borderline personality 
disorder (BPD), dissociation, reckless behaviour, and suicidal ideation and self-injurious 
behaviour (SI/SIB). Third, we investigated the degree of association and comorbidity 
between DSM-5 PTSD and ICD-11 CPTSD, respectively, and depression, anxiety, BPD, and 
SI/SIB. 
Methods 
Participants and procedures 
 Participants were referred by general practitioners, psychiatrists, or psychologists for 
psychological therapy at a National Health Service trauma centre in Scotland (N = 106). The 
sample were primarily female (93.4%) and of British origin (91.3%) with a mean age of 
39.25 years (SD = 10.94, range = 19-62). Most participants had finished post-secondary 
education (56.6%), were currently unemployed (58.1%), and single (59.2%). All participants 
reported experiencing a traumatic life event. The mean number of traumatic life events was 
6.99 (SD = 2.80), and the most commonly reported traumatic experience was physical assault 
(95.1%). 
Measures 
 ICD-11 PTSD and CPTSD: The International Trauma Questionnaire (ITQ Version 
1.2, Cloitre et al., 2015 – formally the ‘ICD-11 Trauma Questionnaire’) is a self-report 
measure of the ICD-11 diagnoses of PTSD and CPTSD. Six items measure the PTSD 
symptoms, 16 items measure the DSO symptoms (9 ‘affective dysregulation’ items, 4 
‘negative self-concept’ items, and 3 ‘disturbances in relationship’ items), and six items 
measure functional impairment associated with both the PTSD and DSO symptoms. 
Individuals respond to each PTSD item in terms of how much they have been bothered by the 
symptom over the past month, and respond to each DSO item in terms of how they typically 
feel, think about themselves, and relate to others. All items are measured using a five-point 
Likert scale ranging from 0 (‘Not at all’) to 4 (‘Extremely’). The endorsement of a symptom/ 
measure of functional impairment is assumed if a person responds with a score of 2 
(‘Moderately’) or greater. The psychometric properties of the ITQ have been validated in 
number of studies, including within a larger sample drawn from the same trauma centre as 
was used in the current study (see Karatzias et al., 2016; Karatzias et al., 2017). The internal 
reliability (Cronbach’s alpha) of the PTSD (α = .74) and DSO (α = .89) items in the current 
sample were satisfactory. 
 DSM-5 PTSD: The Posttraumatic Checklist for DSM-5 (PCL-5: Weathers et al., 
2013) is a self-report measure of the 20 DSM-5 PTSD symptoms. The PCL-5 uses the same 
response format, instructions, and threshold for symptom endorsement as the ITQ. The PCL-
5 has good psychometric properties (Blevins et al., 2015) and the reliability of the scale in the 
current sample was satisfactory (α = .86). 
Depression and Anxiety: The Hospital Anxiety and Depression Scale (HADS: 
Zigmond & Snaith, 1983) is a 14-item, self-report measure. Seven items measure depression 
(α = .65) and anxiety (α = .78), respectively, and each item is scored on a four-point Likert 
scale (0-3). Total scale scores can be calculated where higher scores reflect greater distress, 
and scores of 11 and above are used to indicate clinical cases of anxiety and depression, 
respectively (Zigmond & Snaith, 1983). 
Borderline Personality Disorder: Commented [TK1]: Developed by Marylene. 
Dissociation: The Dissociative Symptoms Scale (DSS-B) (Carlson et al., 2013a) is an 
8-item scale used to assess moderately severe trauma-related intrusions, gaps in awareness or 
memory, and distortions in perceptions of oneself or surroundings that persist after traumatic 
stress. Participants respond to each item using a five-point Likert scale ranging from 0 (‘not 
at all’) to 4 (‘more than once a day’). The internal reliability the DSS-B in the current sample 
was satisfactory (α = .80). 
Reckless Behaviours and SI/SIB: The Structured Interview of Self-Destructive 
Behaviours (SI-SDB: Carlson et al., 2013b) was used to measure reckless behaviours and 
SI/SIB. This is a brief interview that consists of five sections in the domains of substance 
abuse, disordered eating, disordered sexual behaviour, self-injury, and suicidality. Items were 
designed to inquire about behaviours and injuries in a neutral way and do not assume 
intentionality, with the exception self-harm and suicidal behaviours. A total score of ‘reckless 
behaviours’ was calculated from four ‘yes’ (1) or ‘no’ (0) based questions which enquired if 
respondents had ever engaged in (i) illicit drug use, (ii) overspending, (iii) risky sexual 
behaviour, and (iv) reckless driving. Scores ranged from 0-4 and higher scores reflect higher 
levels of reckless behaviour. Additionally, respondents were asked if they have ever had 
thoughts of ending their own life, and if they have ever injured themselves in some way on 
purpose. Both questions were answered on a ‘yes’ (1) and ‘no’ (0) basis. Individuals were 
classified as scoring positive for SI/SIB if they responded ‘yes’ to both questions. 
Analysis 
 The proportion of individuals meeting diagnostic status for DSM-5 PTSD was 
compared to the number of individuals meeting diagnostic status for ICD-11 PTSD and 
CPTSD using a z-test. Independent samples t-tests were used to compare those with an ICD-
11 PTSD diagnosis to those with an ICD-11 CPTSD diagnosis on each dependent variable. 
Cohen’s d effect sizes were used to determine the magnitude of group differences (< .5 small 
effect size, .5-.8 moderate effect size, > .8 large effect size). The associations between DSM-
5 PTSD and ICD-11 CPTSD, and depression, anxiety, BPD, and SI/SIB were assessed using 
a chi-square test (χ2). Odds ratios with 95% confidence intervals (OR 95% CI) were used to 
quantify the level of association. Comorbidity rates associated with DSM-5 PTSD and ICD-
11 CPTSD were compared using a z-test.  
Results 
Prevalence rates and descriptive statistics 
The prevalence rate of DSM-5 PTSD (90.4%) was significantly higher than the 
combined prevalence rate of ICD-11 PTSD and CPTSD (79.8%) (z = 2.14, SE = .05, p = 
.016). The taxonomic structure of the ICD-11 only permits a diagnosis of PTSD or CPTSD; 
not both. Accordingly, most individuals who qualified for a diagnosis under the ICD-11 
guidelines satisfied the criteria for CPTSD (62.5%) rather than PTSD (17.3%). Descriptive 
statistics for each continuously measured variable in the study are reported in Table 1. 
Additionally, 23.2% of the sample reported experiencing SI/SIB. 
Table 1 here 
Factors that differentiate ICD-11 PTSD and CPTSD 
 Results of the independent samples t-tests comparing those with an ICD-11 PTSD 
diagnosis to those with an ICD-11 CPTSD diagnosis on each clinical and behavioural 
variable are reported in Table 2. Those with an ICD-11 CPTSD diagnosis experienced 
significantly (p < .05) higher levels of dissociation (d = 1.01), depression (d = .63), and BPD 
(d = .55). Those with a CPTSD diagnosis were almost three times more likely than those with 
a PTSD diagnosis to report SI/SIB (OR = 2.87, 95% CI = 0.59 – 13.99), however this effect 
was not statistically significant (χ2 = 1.83, df = 1, p = .177). 
Table 2 here 
Association and comorbidity rates for DSM-5 PTSD and ICD-11 CPTSD 
 Table 3 reports the level of association, and comorbidity rates, between ICD-11 
CPTSD and DSM-5 PTSD and depression, anxiety, BPD, and SI/SIB. A diagnosis of ICD-11 
CPTSD was significantly, and strongly, associated with depression (OR = 3.98, 95% CI = 
1.68 – 9.41), anxiety (OR = 5.28, 95% CI = 1.66 – 16.77), and SI/SIB (OR = 3.42, 95% CI = 
1.06 – 11.07). Contrastingly, a DSM-5 PTSD diagnosis was only significantly associated 
with anxiety (OR = 11.32, 95% CI = 2.76 – 46.49). Comorbidity rates were higher for ICD-
11 CPTSD than DSM-5 PTSD with depression (by 10.7%), anxiety (by 4.0%), and SI/SIB 
(by 7.0%), however these differences did not reach the level of statistical significance. 
Notably, ICD-11 CPTSD and DSM-5 PTSD had similarly high levels of comorbidity with 
BPD (98.5% and 97.9%, respectively). 
Table 3 here 
Discussion 
 The primary aim of the current study was to identify clinical and behavioural 
correlates of PTSD/CPTSD as described by the two major diagnostic classification systems 
within a clinical sample characterised by a history of frequent traumatic exposure. In doing 
so, we sought to identify clinical and behavioural factors that serve to distinguish an ICD-11 
CPTSD diagnosis from an ICD-11 PTSD diagnosis; and to provide evidence regarding the 
relative severity of ICD-11 CPTSD and DSM-5 PTSD.  
 Consistent with prior findings (Hansen et al., 2015; Hyland et al., 2017b; O’Donnell 
et al., 2014), a significantly greater proportion of individuals met diagnostic criteria based on 
the DSM-5 guidelines compared to the ICD-11 guidelines. There is now consistent evidence 
derived from a range of clinical samples characterised by distinct traumatic histories, cultural 
identities, and methods of data collection indicating that the ICD-11 provides a stricter 
criteria than the DSM-5 for diagnosis of trauma-related psychopathology.  
How such findings should be interpreted has become an issue of contention. It has 
been argued that the DSM-5 system should be favoured as it maximizes the likelihood that 
traumatized individuals will qualify for a diagnosis (Wisco et al., 2016). These authors 
expressed concern that adoption of the seemingly stricter ICD-11 criteria would have 
substantial public health implications as it would limit access to health care services for 
trauma-exposed persons. Such an argument is problematic for several reason. First, the 
concern for the need for a diagnosis so as to receive access to health care is a highly 
Americentrist concern where access to health care is highly dependent upon receiving a 
diagnosis so that a person is entitled to insurance coverage. In all other developed nations 
which guarantee access to health care for all people, such motivations are far less relevant. 
Although it is important that psychologists are cognizant of the social and political 
implications of their research, it should not - and cannot - be the case the scientific research 
be influenced in any way by the specific vagaries of one nation’s insurance and health care 
policies. Second, the argument advanced by Wisco et al. makes the implicit assumption that 
the ‘orphans’ of the ICD-11 system will not qualify for another psychiatric diagnosis. Given 
the extensive literature attesting to the high levels of comorbidity associated with PTSD 
(Flory & Yehuda, 2015), it may well be the case that such individuals will satisfy the 
diagnostic criteria for another psychiatric disorder. To date, there is simply no evidence that 
has examined the clinical characteristics of those individuals who meet the diagnostic criteria 
for DSM-5 PTSD but not ICD-11 PTSD or CPTSD. A systematic body of work is now 
required to determine if the ICD-11 orphans qualify for another diagnosis or not. If these 
individuals display significant daily-life distress and impairment, and fail to qualify for 
another diagnosis, the ICD-11 could be reasonably viewed as being overly restrictive and 
prone to yielding a higher number of false negative diagnoses relative to the DSM-5. 
Alternatively, if it is the case that these individuals display low levels of daily-life distress 
and impairment, or qualify for another psychiatric diagnosis, the ICD-11 could be viewed as 
providing a more specific diagnostic profile that is more accurately aligned to the 
symptomatology of a given patient relative to the DSM-5. Until the pertinent empirical data 
is available, it may be said that the DSM-5, with its broad symptom profile and inclusive 
diagnostic threshold, favours diagnostic sensitivity so as to minimize false negative 
diagnoses; whereas the ICD-11, with is narrow symptom profile and stricter diagnostic 
threshold, favours diagnostic specificity so as to minimize false positive diagnoses.  
 With a growing body of empirical support for the construct validity of ICD-11 
CPTSD as a unique disorder, the need for clinical interventions tailored to address the 
specific symptom profile of the disorder becomes increasingly necessary (Ford, 2015). 
Identification of unique clinical and behavioural features associated with a diagnosis of ICD-
11 CPTSD may help to guide clinical interventions. Our findings indicated that those 
individuals who qualified for an ICD-11 CPTSD diagnosis, as compared to an ICD-11 PTSD 
diagnosis, were distinguished most clearly on the basis of experiencing higher levels of 
dissociation; a finding that is consistent with those reported by Elklit et al. (2014). How to 
most accurately conceptualise dissociative experiences within theoretical models of PTSD 
has been a matter of debate (see Dalenberg & Carlson, 2012); nonetheless, extant results 
suggest that dissociation is a strong distinguishing factor between CPTSD and PTSD, as per 
the ICD-11 proposals. Additionally, those with a CPTSD diagnosis also displayed 
significantly higher levels of depression, BPD, and non-significantly higher levels of anxiety, 
reckless behaviour, and SI/SIB. Taken together, these findings provide evidence that CPTSD 
is a diagnosis that is associated with substantially greater psychological distress than a 
diagnosis of PTSD. Current findings add to the existing literature which has consistently 
shown that CPTSD is associated with significant functional impairment in daily living by 
highlighting the high levels of psychiatric burden that is also associated with a CPTSD 
diagnosis.  
 Our findings also suggest that ICD-11 CPTSD may be a more severe and distressing 
diagnosis than DSM-5 PTSD. The associations between ICD-11 CPTSD and depression, 
anxiety, and SI/SIB were all positive, statistically significant, and of a robust magnitude. 
Furthermore, in the case of depression and SI/SIB, the associations were stronger for ICD-11 
CPTSD than DSM-5 PTSD, while the association with anxiety was stronger for DSM-5 
PTSD. Furthermore, and congruent with the only other assessment of comorbidity rates 
between ICD-11 CPTSD and DSM-5 PTSD (Powers et al., 2017), the former yielded higher 
comorbidity estimates with depression and SI/SIB, most notably, and to a lesser degree with 
anxiety and BPD, however it is important to stress that the difference in these comorbidity 
rates did not reach statistical significance.  
These findings are important for several reasons. First, the higher rates of comorbidity 
associated with CPTSD are inconsistent with the ICD-11 proposals which aimed to reduce 
comorbidity with other disorders. Second, whether one adopts the use of the DSM-5 system 
or the ICD-11 system, the level of comorbidity with these clinical and behavioural measures 
was exceptionally high. Third, the conceptualisation of ICD-11 CPTSD as a unique 
diagnostic entity has been criticised as being indistinguishable from other disorders, most 
notably BPD (Resick et al., 2012). Although previous work has empirically supported the 
discriminant validity of ICD-11 CPTSD from BPD, and identified the features that 
distinguish the two conditions (Cloitre et al., 2014), findings from the current study indicate 
that BPD and CPTSD may indeed share much in common. Almost all individuals who met 
diagnostic status for CPTSD also met diagnostic status for BPD (98.5%). However, if one 
were to argue on the basis of such a result that ICD-11 CPTSD is not a valid diagnostic 
construct, then DSM-5 PTSD must also be regarded as invalid as the comorbidity rate with 
BPD was equally high (97.9%). Each of these findings can however be easily understood 
through the perspective of a dimensional model of psychopathology (see Kotov et al., 2016) 
rather than the categorical model of psychopathology favoured by the DSM and the ICD. 
According to the dimensional model of psychopathology, “disorders” such as PTSD, CPTSD, 
depression, anxiety, and BPD are all observable manifestations of an underlying 
‘Internalizing’ psychopathology latent variable. As such, these disorders are expected to 
strongly covary given their shared underlying latent variable; and the more precisely each 
disorder is measured, the higher the level of covariation should be. Based on the dimensional 
model of psychopathology, higher comorbidity rates for the ICD-11 are to be expected if the 
narrowed symptom profile does indeed more precisely capture the psychopathology 
associated with traumatic exposure.   
 There are several limitations with the current study that should be recognised. The 
analyses were based on a small clinical sample meaning that there was an increased 
likelihood of Type 2 errors occurring. The limited statistical power may explain the null 
effects for the differences in comorbidity rates across the diagnostic systems despite the 
observed differences. Furthermore, the predominately female composition of the sample 
limits the generalizability of findings to the wider trauma population. The clinical/ diagnostic 
status of disorders in the current study were based on self-report assessments rather than 
clinician-administered interviews. It is possible that the self-report nature of the data may 
have biased results, however this limitation was constant across all aspects of the current 
study meaning that any such biases that may have resulted from the use of self-report 
assessments are unlikely to have influenced the main findings of the study. Finally, the high 
prevalence of BPD is likely to have yielded the null effects for the association between it and 
ICD-11 CPTSD and DSM-5 PTSD. Future work with larger and more varied samples is 
required to replicate the current findings. 
 In conclusion, several important findings and directions for future research emerge 
from the current study. Once again it was found that the ICD-11 produces fewer clinical cases 
relative to the DSM-5, and given the consistency of this finding it is now necessary to focus 
on the characteristics of those persons who meet diagnostic status according to one system 
but not the other. Such work should provide vital information to better understand the clinical 
benefits or limitations associated with the use of one system over the other. Additionally, 
current findings indicate that a diagnosis of ICD-11 CPTSD can be distinguished from ICD-
11 PTSD on the basis of higher levels of dissociation, depression, and BPD. CPTSD also 
appears to be associated with high levels of psychiatric distress as compared to both an ICD-
11 and a DSM-5 PTSD diagnosis. This highlights the need for specialised clinical 
interventions targeted specifically at the unique symptoms, and correlates, of CPTSD.  
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Table 1. Descriptive statistics of all continuous variables 
 Mean (SD) 95% CI of the Mean Median Range 
Depression 10.93 (5.13) 9.95 – 11.92 11 0-20 
Anxiety 14.63 (5.18) 13.64 – 15.63 15.50 0-21 
Borderline Personality Disorder 10.47 (2.34) 9.99 – 10.95 11 4-14 
Dissociation 12.06 (6.51) 10.74 – 13.38 11 4-35 
Reckless behaviour 0.97 (0.94) 0.78 – 1.16 1 0-4 
Note: 95% CI = 95% confidence interval; SD = Standard Deviation. 
  
Table 2. Independent samples t-tests comparing those with ICD-11 PTSD and CPTSD diagnoses on each continuously measured clinical and 
behavioural measure. 
Variable ICD-11 PTSD ICD-11 CPTSD    
 Mean (SD) Mean (SD) t (df) p d 
Depression 9.73 (3.71) 12.43 (4.76) 2.05 (78) .044 .63 
Anxiety 14.20 (3.23) 16.14 (4.55) 1.56 (78) .123 .49 
Borderline Personality Disorder 9.69 (3.01) 11.09 (1.94) 2.10 (68) .040 .55 
Reckless behaviour 0.80 (.78) 1.13 (1.01) 1.19 (74) .239 .37 
Dissociation 9.00 (3.36) 14.37 (6.76) 2.98 (73) .004 1.01 
Note: PTSD = Posttraumatic stress disorder; CPTSD = Complex PTSD; t (df) = t value and degrees of freedom; p = statistical significance; d = 
Cohen’s d effect size; SD = standard deviation. 
 
  
Table 3. Associations between ICD-11 CPTSD and DSM-5 PTSD and clinical and behavioural outcomes. Degree of comorbidity and differences 
in comorbidity also reported. 
Note: OR (95% CI) = Odds ratio with 95% confidence interval; BPD = borderline personality disorder; SI/SIB = suicidal ideation and 
self-injurious behaviour; z = z-test comparing differences in comorbidity proportions; statistical significance = * p < .05, ** p < .01, 
*** p < .001 
Diagnosis % with Depression 
OR (95% CI) 
% with Anxiety 
OR (95% CI) 
% with BPD 
OR (95% CI) 
% with SI/SIB 
OR (95% CI) 
ICD-11 CPTSD 69.2% 
3.98 (1.68 – 9.41)** 
92.3% 
5.28 (1.66 – 16.77)** 
98.5% 
1.83 (0.11 – 30.14) 
30.6% 
3.42 (1.06 – 11.07)* 
DSM-5 PTSD 58.5% 
2.12 (0.56 – 8.00) 
88.3% 
11.32 (2.76 – 46.49)*** 
97.9% 
5.11 (0.42 – 62.03) 
23.6% 
1.08 (0.21 – 5.61) 
Differences in Comorbidity 10.7% 4.0% 0.6% 7.0% 
 z = 1.38, p = .08 z = 0.83, p = .20 z = -0.38, p = .65 z = 0.27, p = .39 
